Fatty liver

16:10 - 22 May , 2021

Disease

What is Fatty liver?

Is a pathology where there is an over-accumulation of fat in the liver, which causes inflammation and problems for its proper functioning.  Potential causes and risks: So far, two types of fatty liver have been described, the first is the result of high alcohol consumption, and the second not attributable to alcohol intake. In addition to alcoholism, there are other important potential risks, such as being overweight and obese, high levels of cholesterol and triglycerides in the blood, high blood pressure, diabetes, and other metabolic diseases, as well as the consumption of certain medications whose use for long periods can trigger this condition.

Symptoms

Usually, fatty liver disease does not show any symptoms until it is in a more advanced stage. When this happens, some signs may appear such as pain in the upper right area of the abdomen, fatigue, apathy, and weight loss.

Diagnosis and treatment

To make an accurate diagnosis, it is necessary to review your medical history, know your eating habits, your level of alcohol consumption, and the medications you take. In addition to this and to confirm the diagnosis, your doctor may order blood tests and a liver biopsy. The treatment to be followed will largely depend on the cause and the stage of the disease. If the cause is attributed to high alcohol consumption, treatment will focus on reducing or eliminating alcohol intake. In any case, changes in your diet and exercise will be recommended to help you lose weight and prevent the condition from progressing.  At the Nutrition & Obesity Center we offer you comprehensive care according to your needs to help you have a healthy lifestyle, control your weight, change your body composition, prevent and manage associated diseases, as well as improve your physical and sports performance. We have specialized schemes for accelerated and sustained weight loss under the supervision of a multidisciplinary team, based on safe and scientifically supported methods.

Fuentes: 

  • mayoclinic.org
  • cigna.com
  • sos-bariatria.com
  • medlineplus.gov
  • medigraphic.com
  • Csendes GP, Paolinelli GP, Busel MD, Venturelli AV, Rodríguez J. Hígado graso: ultrasonido y correlación anatomopatológica. Rev Chil Radiol. 2004; 10 (2): 50-52.
  • Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic teatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001; 121: 91-100
  • Lizardi-Cervera J, Becerra LI, Chávez-Tapia NC et al. Prevalencia de hígado graso no alcohólico y síndrome metabólico en población asintomática. Rev Gastroenterol Mex. 2006; 71 (4): 453-459.
  • Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl Med. 2010; 363 (4): 1341-1350.
  • Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology. 1990; 12: 1106-1110.

						
The dissemination of the content of this material is for informational purposes only and does not replace, under any circumstance or condition, a consultation with a specialist doctor, for which the ABC Medical Center is not responsible for the different use that may be given to it. If you require more information related to the subject, we suggest you contact the specialist doctor you trust directly.